MedPath

A study to compare spinal Bupivacaine and Ropivacaine, each with fentanyl in lower limb surgeries in adults

Phase 4
Completed
Conditions
Health Condition 1: M259- Joint disorder, unspecifiedHealth Condition 2: null- patients with orthopedic lower limb surgical intervention free from other systemic diseases were chosen
Registration Number
CTRI/2022/01/039595
Lead Sponsor
ady Hardinge medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

1) ASA grade I and II

2) Patients scheduled for lower limb surgeries

Exclusion Criteria

1) Patients with ASA grade III and IV

2) History of known hypersensitivity to any drugs being used

3) Mental disturbances

4) Contraindications to neuraxial blockade

5) BMI � 40 kg/m2

6) Surgery lasting for > 2hours

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) Duration of sensory block assessed by regression of the sensory level to T-10 dermatome (by Hollmen scale ) <br/ ><br>2) Duration of motor block assessed by time to achieve the Bromage- 0 (in minutes by modified Bromage scale) <br/ ><br>Timepoint: Every 10 minutes
Secondary Outcome Measures
NameTimeMethod
1) Heart rate and mean blood pressure will be measured every 30 minutes for first 2 hours and then 1 hourly. <br/ ><br>2) Side effects- headache, nausea, vomiting, numbness, pain, weakness. <br/ ><br>3) A VAS score of more than or equal to 4 would be marked as end of effective analgesia & patient will be administered rescue analgesia. <br/ ><br>Timepoint: Heart rate and mean blood pressure will be measured every 30 minutes for first 2 hours and then 1 hourly.
© Copyright 2025. All Rights Reserved by MedPath